management

Jed Latkin

CEO

Jed was appointed CEO of Windtree Therapeutics on December 1, 2024, and will continue to serve as a member of the Board which he has been a member of since October 2024. He has nearly three decades of financial and biotech experience, including as CEO of a public biotech company. As the CEO of Navidea Biopharmaceuticals, Jed  executed deals and raised substantial funds, and also held the position there as the Chief Financial Officer. Most recently, he performed as both the Chief Operating Officer and Head of Finance at ProPhase Labs for the past two years, conducting deals and managing broad aspects of the business. Jed’s experience also includes serving as a CEO of Black Elk Energy Offshore in 2014 as part of Nagel Avenue Capital, which he joined after working for over ten years on Wall Street with a variety of investment banking organizations and funds, including ING, Morgan Stanley and Citigroup Securities.

Jed earned a Master of Business Administration from Columbia University and a Bachelor of Science degree from Rutgers University, graduating with honors and Phi Beta Kappa.

Eric Curtis

PRESIDENT AND CHIEF OPERATING OFFICER

Eric joined Windtree in March 2020 having most-recently served as the Chief Executive Officer and President of Centurion Biopharma Corp. (Centurion), an oncology research and development company and President and Chief Operating Officer of CytRX Corporation, a biopharmaceutical company and Centurion’s parent company, since February 2018. Prior to joining Centurion, Eric served as Principal of Curtis Biopharm Consulting, where he provided strategic consultancy services to a variety of healthcare-focused companies, including Windtree, from May 2016 to January 2018. From 2014 to May 2016, he held the position of President, U.S. Commercial at Aegerion Pharmaceuticals (now Novelion Therapeutics). Prior to those roles, Eric was VP/GM of the Cardiopulmonary BU at Bayer, Global Commercial Leader and VP of Marketing at GlaxoSmithKline and held senior marketing and sales roles at Johnson & Johnson.

Eric earned a Master of Business Administration from Pennsylvania State University as well as a Bachelor of Science degree from the University of Pittsburgh.

Steve Simonson, M.D.

Senior Vice President and Chief Medical Officer

Steve was appointed Windtree’s Vice President of Clinical Development in May of 2014 and has served as the Company’s Senior Vice President and Chief Medical Officer since October 2014.

Steve brings a significant background in pulmonary critical care, with more than 25 years of medical practice and pharmaceutical industry clinical trial expertise including all phases of drug development. Prior to joining Windtree, Steve held executive positions with several companies including Executive Director in the Molecular Development Group at Covance, Vice President of Clinical Development at Agennix, Inc., and various positions at AstraZeneca, where he spent 15 years in medical and clinical leadership.

Steve received his medical degree from the Medical College of Wisconsin, his Masters of Health Sciences degree in Biometry from Duke University School of Medicine, and completed his training in internal medicine followed by a fellowship in pulmonary and critical care medicine at Duke University Medical Center.

Jamie McAndrew

SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER

Jamie was appointed Windtree’s Senior Vice President and Chief Financial Officer in September 2024.  She previously served as Windtree’s Vice President, Controller, and Chief Accounting Officer since August 2023. 

Jamie has over 20 years of experience in accounting, finance, and biotech. She has held various roles at Windtree since joining the company in November 2013, including Director of Accounting and Reporting, Controller, and Executive Director and Corporate Controller. Prior to joining Windtree, from January 2008 to October 2013, Jamie worked in public accounting at KPMG LLP, holding positions of increasing responsibility in audit and transaction services, where she worked extensively on buy-side financial due diligence for potential acquisitions. 

Jamie received her Bachelor of Arts in Philosophy and Political Science from Villanova University and her Master of Professional Accountancy from the J. Mack Robinson College of Business at Georgia State University. Jamie is also a certified public accountant.

George Cox

Vice President of Technical Operations

George Cox was appointed Windtree’s Vice President of Technical Operations in April 2008 and is responsible for the global manufacturing, quality and logistics of clinical drugs and supplies for the company.

Mr. Cox brings over 35 years of experience in global manufacturing, clinical supply and international cold chain logistics. Prior to joining Windtree, Mr. Cox served as Senior Director of Supply Chain for Auxilium Pharmaceuticals and at MedImmune, Inc. While at MedImmune, he was instrumental in obtaining government funding for the then pandemic preparedness. Before this position, Mr. Cox held various positions of increasing responsibilities at Rhone-Polenc Rorer Pharmaceuticals, Uniform Tubes and Proctor-Silex. His experience spans the pharmaceutical and biotech industries in small start-ups, as well as large pharma.

Mr. Cox earned his Bachelor of Science in Accounting at Villanova University.